TearLab Corp (TEAR) - Financial and Strategic SWOT Analysis Review
TearLab Corp (TEAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
TearLab Corp (TearLab) is an in-vitro diagnostic company which focuses on ophthalmic devices. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship product TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. TearLab conducts research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. It sells products directly in the US, Canada and the UK. The company also sells products through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.
TearLab Corp Key Recent Developments
Aug 08,2019: TearLab reports second quarter and first half 2019 financial Results
May 09,2019: TearLab reports first quarter 2019 financial results
Mar 21,2019: TearLab reports fourth quarter and full year 2018 financial results
Nov 07,2018: TearLab reports third quarter 2018 financial results
Aug 09,2018: Tearlab reports second quarter and first half 2018 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
TearLab Corp (TearLab) is an in-vitro diagnostic company which focuses on ophthalmic devices. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship product TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. TearLab conducts research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. It sells products directly in the US, Canada and the UK. The company also sells products through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.
TearLab Corp Key Recent Developments
Aug 08,2019: TearLab reports second quarter and first half 2019 financial Results
May 09,2019: TearLab reports first quarter 2019 financial results
Mar 21,2019: TearLab reports fourth quarter and full year 2018 financial results
Nov 07,2018: TearLab reports third quarter 2018 financial results
Aug 09,2018: Tearlab reports second quarter and first half 2018 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
TearLab Corp - Key Facts
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Major Products and Services
TearLab Corp - History
TearLab Corp - Company Statement
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TearLab Corp - Business Description
TearLab Corp - SWOT Analysis
SWOT Analysis - Overview
TearLab Corp - Strengths
TearLab Corp - Weaknesses
TearLab Corp - Opportunities
TearLab Corp - Threats
TearLab Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
TearLab Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Aug 08, 2019: TearLab reports second quarter and first half 2019 financial Results
May 09, 2019: TearLab reports first quarter 2019 financial results
Mar 21, 2019: TearLab reports fourth quarter and full year 2018 financial results
Nov 07, 2018: TearLab reports third quarter 2018 financial results
Aug 09, 2018: Tearlab reports second quarter and first half 2018 financial results
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
TearLab Corp - Key Facts
TearLab Corp - Key Employees
TearLab Corp - Key Employee Biographies
TearLab Corp - Major Products and Services
TearLab Corp - History
TearLab Corp - Company Statement
TearLab Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
TearLab Corp - Business Description
TearLab Corp - SWOT Analysis
SWOT Analysis - Overview
TearLab Corp - Strengths
TearLab Corp - Weaknesses
TearLab Corp - Opportunities
TearLab Corp - Threats
TearLab Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
TearLab Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Aug 08, 2019: TearLab reports second quarter and first half 2019 financial Results
May 09, 2019: TearLab reports first quarter 2019 financial results
Mar 21, 2019: TearLab reports fourth quarter and full year 2018 financial results
Nov 07, 2018: TearLab reports third quarter 2018 financial results
Aug 09, 2018: Tearlab reports second quarter and first half 2018 financial results
May 10, 2018: TearLab Announces First Quarter 2018 Financial Results
Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange
Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
TearLab Corp, Key Facts
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Major Products and Services
TearLab Corp, History
TearLab Corp, Subsidiaries
TearLab Corp, Key Competitors
TearLab Corp, Ratios based on current share price
TearLab Corp, Annual Ratios
TearLab Corp, Annual Ratios (Cont...1)
TearLab Corp, Interim Ratios
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
TearLab Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
TearLab Corp, Key Facts
TearLab Corp, Key Employees
TearLab Corp, Key Employee Biographies
TearLab Corp, Major Products and Services
TearLab Corp, History
TearLab Corp, Subsidiaries
TearLab Corp, Key Competitors
TearLab Corp, Ratios based on current share price
TearLab Corp, Annual Ratios
TearLab Corp, Annual Ratios (Cont...1)
TearLab Corp, Interim Ratios
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
TearLab Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
TearLab Corp, Performance Chart (2014 - 2018)
TearLab Corp, Ratio Charts
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
TearScience Inc
LacriSciences, LLC
DiagnosTear Ltd.
Advanced Tear Diagnostics, LLC
TearLab Corp, Performance Chart (2014 - 2018)
TearLab Corp, Ratio Charts
TearLab Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
TearLab Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
TearScience Inc
LacriSciences, LLC
DiagnosTear Ltd.
Advanced Tear Diagnostics, LLC